Amphivena Therapeutics Receives $14,000,000 New Funding

  • Feed Type
  • Date
    5/4/2015
  • Company Name
    Amphivena Therapeutics
  • Mailing Address
    45 Juniper Street San Francisco, CA 94103 USA
  • Company Description
    Amphivena Therapeutics Inc., a newly created subsidiary of venture-backed Affimed Therapeutics AG , has raised $14 million in Series A financing and has granted Janssen Biotech an exclusive option to acquire the company.
  • Website
    http://www.amphivena.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy